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Background: Oral-facial-digital type 1 syndrome (OFD1; OMIM 311200) belongs to the expanding group of
disorders ascribed to ciliary dysfunction. With the aim of contributing to the understanding of the role of primary
cilia in the central nervous system (CNS), we performed a thorough characterization of CNS involvement observed
in this disorder.
Methods: A cohort of 117 molecularly diagnosed OFD type I patients was screened for the presence of neurological
symptoms and/or cognitive/behavioral abnormalities on the basis of the available information supplied by the
collaborating clinicians. Seventy-one cases showing CNS involvement were further investigated through neuroimaging
studies and neuropsychological testing.
Results: Seventeen patients were molecularly diagnosed in the course of this study and five of these represent new
mutations never reported before. Among patients displaying neurological symptoms and/or cognitive/behavioral
abnormalities, we identified brain structural anomalies in 88.7%, cognitive impairment in 68%, and associated
neurological disorders and signs in 53% of cases. The most frequently observed brain structural anomalies included
agenesis of the corpus callosum and neuronal migration/organisation disorders as well as intracerebral cysts,
porencephaly and cerebellar malformations.
Conclusions: Our results support recent published findings indicating that CNS involvement in this condition is found
in more than 60% of cases. Our findings correlate well with the kind of brain developmental anomalies described in
other ciliopathies. Interestingly, we also described specific neuropsychological aspects such as reduced ability in
processing verbal information, slow thought process, difficulties in attention and concentration, and notably, long-term
memory deficits which may indicate a specific role of OFD1 and/or primary cilia in higher brain functions.
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Primary cilia are microtubule-based organelles protruding
from the surface of most mammalian cells, including
neuronal cells, which exert mainly sensory functions
[1]. Human disorders associated with ciliary dysfunction
are called “ciliopathies” and present phenotypes that vary
from renal and hepatic cystic disease to neurologic pheno-
types, disorders of laterality, obesity, and skeletal disorders.* Correspondence: franco@tigem.it
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article, unless otherwise stated.In particular, central nervous system (CNS) involvement
includes intellectual disability and a wide range of brain
structural abnormalities [2].
To date various ciliopathies have been identified,
including pleiotropic disorders such as the OFD type
1 (OFD1), Bardet-Biedl syndrome (BBS), Joubert syn-
drome and related disorders (JSRDs), Meckel-Gruber
syndrome (MKS) [1].
OFD type 1 syndrome (OFD1; OMIM 311200) is a rare
X-linked-dominant male-lethal developmental disorder
which was first described by Papillon-Leage and Psaume
in 1954 [3]. The disease belongs to the heterogeneous
group of disorders known as oral–facial–digital syndromesntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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the face, oral cavity, and digits with a high degree of intra-
familial and interfamilial phenotypic variability possibly
due to X chromosome inactivation [6]. CNS involvement
is reported in 60% of cases and includes brain structural
abnormalities, intellectual disability and/or selective cog-
nitive impairment. Renal cystic disease is reported in the
majority of cases occurring in patients older than 18
[5,7-9]. OFD type 1 syndrome is caused by mutations in
the Cxorf5 transcript, subsequently named OFD1 [10,11].
To date, 130 different mutations (9 genomic deletions and
121 point mutations, mostly represented by frameshifts
resulting in truncating forms of the protein) have been
identified in OFD type 1 cases. Over 70% of patients rep-
resent sporadic cases, and no clear genotype/phenotype
correlation has been established (reviewed in [5] and [9]).
Interestingly OFD1 has also been found mutated in a
X-linked recessive intellectual disability syndrome com-
prising macrocephaly and ciliary dysfunction [12], in
X-linked Joubert syndrome [13-16], and more recently
in X-linked retinitis pigmentosa [17]. Retinitis pigmentosa
is not commonly found in OFD type 1 as often as the
recurrent respiratory tract infections described in Budny
et al. On the contrary there are significant similarities
between the CNS phenotype described in JSRDs and OFD
type 1 (see discussion). To date no clear genotype-
phenotype correlation has been established concerning
the involvement of OFD1 in these different genetic
conditions.
The OFD1 gene encodes a centrosomal/basal body
protein localized at the base of primary cilia [18,19].
Characterization of in vitro (Ofd1-silenced cells and ES
cells depleted for the Ofd1 transcript) and in vivo (null
mutants) models demonstrated that, similar to what is
described for other ciliary proteins, inactivation of the
Ofd1 transcript is associated with defective Sonic hedge-
hog (Shh) and canonical Wnt signaling pathways [20-22].
Both pathways are critical for the proper development
of the CNS. Functional studies have demonstrated that
OFD1 has a crucial role in the formation of primary cilia,
thus ascribing this pleiotropic disease to the growing
number of disorders associated with dysfunction of
primary cilia [20].
Previous studies aimed at defining the neuropathological
aspects of OFD1 syndrome were based on a collection of
cases in which a molecular diagnosis was not available
[23-26]. Recent data reported both evaluation of brain
MRIs from seven molecularly diagnosed OFD1 patients
[9] and a role for Ofd1 in dorso-ventral patterning and
axoneme elongation during embryonic brain development
in the mouse [27]. Our larger cohort case study adds
additional information towards a detailed characterization
of the different types of CNS involvement observed in
OFD1 patients.Materials and methods
Collection of patients
A cohort of 117 female cases with a clinical and molecular
diagnosis of OFD type 1 syndrome was assembled through
an international effort. Most patients come from Europe
(>65%) and North America (>19%), and the remaining
from Australia, the Middle East and Asia. The majority of
cases were Caucasians. Patients were assessed by clinicians
at genetics centers worldwide and referred to the partici-
pating laboratories for mutation analysis of the OFD1
gene. DNA or peripheral blood samples were accompanied
by clinical data. The inclusion criteria were the presence of
the Oral-facial-digital attributes characteristics of the OFD
type 1 syndrome and, for the familial cases, the X-linked
dominant-male lethal pattern of inheritance that is typical
for OFD1.
The caring physicians evaluated this cohort of patients.
On the basis of the available information supplied by the
collaborating clinicians, we identified a selected cohort
of seventy-one cases showing CNS involvement defined as
any impairment of brain function (neurological symptoms,
and/or cognitive/behavioral abnormalities) and/or structure
(malformation/structural abnormalities) as evidenced on
one hand by neurological examination, neuropsychological
assessment, neurophysiological tests such as EEG and on
the other by neuroimaging studies.
This selected cohort was further investigated through
detailed neuroimaging studies as well as neurological
examination. Neuropsychological testing by means of an
ad hoc protocol was also proposed to the participating
centers.
Standard protocol approvals and patient consents
Written informed consent was obtained from all patients
(or guardians) participating in the study. The study was
approved by the French CPP (Comité de Protection des
Personnes). Approval from an ethical committee was also
obtained by the other universities and research institutes
involved in this study.
Mutation analysis
Mutation analysis was performed as described [7,8]. Nega-
tive cases were subjected to semiquantitative fluorescent
multiplex method (QFMPSF), and relative quantification
by real-time PCR (qPCR) to identify genomic rearrange-
ments as described [28]. For all mutations 200 normal
X-chromosomes from ethnically matched individuals
were analyzed. Sequence variants were checked using
the Mutalyzer program (www.LOVD.nl/mutalyzer) [29].
Nucleotide changes were verified and analyzed at http://
genome.ucsc.edu/cgi-bin/hgGateway and at the single nu-
cleotide polymorphism database at http://www.ncbi.nlm.
nih.gov/projects/SNP/. Changes affecting splice-donor/ac-
ceptor-sites and flanking sequences were tested with the
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seq_tools/splice.html.
Neuroimaging
Magnetic Resonance Imaging (MRI) of the brain was
performed following a standard protocol which included
the following sequences: a) Turbo-Field-Echo (TFE) iso-
metric 3-dimensional sagittal T1-weighted (T1-w) images
with coronal and axial reconstructions and sagittal; b)
axial and coronal Turbo-Spin-Echo (TSE) T2-weighted
(T2-w) images; c) axial Fluid Attenuation Inversion Re-
covery (FLAIR) images and d) T1-w Inversion Recovery
(IR) images.
Computed Tomography (CT) brain scans were all
carried out without injection of contrast medium, with
an average of 16 sections (4 mm thickness), using 100–
150 mA in order to reduce the radiating dose.
Cranial ultrasonography (CUS) was performed using
microconvex and multifrequency phase array transduc-
ers (5–7.5-10 MHz). The anterior fontanel was used as a
window for standard coronal and sagittal planes, and in
addition the whole brain was scanned to obtain a global
view of the peri- and intraventricular areas and of the
more superficial structures.
Post-mortem brain CT was performed with multislice
spiral acquisition, while PM MRI included axial 3D ciss
T2-w, 3D Flash T1-w, and Diffusion weighted (DW) se-
quences that were subsequently reconstructed on sagittal
and coronal planes.
All supra- and infratentorial brain structures were
evaluated on a qualitative basis, also for the lack of normal
reference values in the paediatric age group.
Of note, it should be emphasized that the definition of
CT is quite limited compared to MRI, particularly for
the structures of the posterior fossa.
Neurological and neuropsychological assessment
For each patient an accurate neurological examination
protocol that included all the standard procedures was
carried out.
The protocol proposed for developmental and neuro-
psychological assessment consisted of a battery of tests
tailored to the patients’ age, cognitive level and degree of
cooperation. Developmental assessment was carried out
by means of the Griffiths Mental Development Scales
(GMDS) for children aged 0–8 years, including six sub-
scales: locomotor, personal-social, language, eye and hand
coordination, performance and practical reasoning. Level
of cognitive ability was tested with the Wechsler scales,
namely the Wechsler Preschool and Primary Scale of
Intelligence (WPPSI), the Wechsler Intelligence Scale for
Children-IV (WISC) or the Wechsler Adult Intelligence
Scale (WAIS), according to the [patient] child’s chrono-
logical age. In addition to the traditional Verbal IQ (VIQ),Performance IQ (PIQ), and Full Scale IQ (FSIQ) scores,
four new indexes were introduced to study cognitive
functions in further detail: the Verbal Comprehension
Index (VCI), the Perceptual Organization Index (POI),
the Freedom from Distractibility Index (FDI), and the
Processing Speed Index (PSI) [30].
Intellectual disability was classified on the basis of the
FSIQ score according to the Diagnostic and Statistic
Manual of Mental Disorders (DSM-IV-TR): mild (50–69),
moderate (35–49), severe (20–34), profound (below 20); a
FSIQ between 70 and 84 indicated borderline intellectual
functioning [31].
Motor and visual coordination was tested with the De-
velopmental Test of Visual-Motor Integration (VMI) [32].
Visual/verbal learning and memory were tested with the
Test of Memory and Learning (TOMAL) [33]. Visuo-
spatial processing was assessed with the Rey-Osterreith
Complex Figure test [34,35]. A subset of cases underwent
a detailed assessment of language abilities according to
the proposed neuropsychological protocol in which
language tests were different according to mother tongues.
In the three selected cases of whom we described in detail,
the neuropsychological findings of Italians were analysed by
means of the following tests: “Test del primo linguaggio”
for children aged 18–36 months [36]; “TVL-Test di valu-
tazione del linguaggio” [37] for children aged 3 to 6 years;
Batteria per la valutazione dei disturbi del linguaggio in
età evolutiva [38] for children aged 6 to 11.5 years.
Executive functions were evaluated with the Wisconsin
Card Sorting Test, which measures the appropriateness
of problem solving strategies in achieving a goal [39].
The behavioral and psychiatric assessment was per-
formed with the Child Behavior Checklist (CBCL). The
CBCL is a parent-report questionnaire with which the
child can be rated on various behavioral and emotional
problems. It assesses internalizing (i.e., anxious, depres-
sive, and overcontrolled) and externalizing (i.e., aggres-
sive, hyperactive, noncompliant, and undercontrolled)
behaviors [40].
Genotype-phenotype correlations
Possible genotype-phenotype correlation between each
phenotypic neurological signs, brain structural abnormal-
ities and cognitive defect, and type and position of muta-
tions was investigated using contingency table analysis. The
analyses of each phenotypic parameter were performed
separately. The results were analysed by Fisher’s exact test
to overcome the problem of small sample sizes.
Results
Mutational analysis
Mutations have previously been described for one hundred
OFD1 patients [7,8,11,28]. Seventeen additional sporadic
cases were identified.
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region and introns flanking sequences of the OFD1
transcript was performed. Negative cases were then
subjected to quantitative analysis to identify genomic
rearrangements. These methods allowed the identifi-
cation of 17 mutations reported in Table 1, which are
scattered along the first 17 exons of the OFD1 transcript
that comprises 23 coding exons and encodes a 1011
Aa protein, as described [5]. Five out of the 17 point
mutations and two genomic rearrangements were never
reported before.
CNS involvement in OFD type 1
Based on available clinical information we selected all
molecularly diagnosed OFD1 cases showing neurological
symptoms and/or signs or cognitive/behavioral abnor-
malities (our selected cohort of seventy-one out of 117,
60,68%). The age ranged from 3 to 61 years, with the
majority of patients being <18 years of age. Two cases
were represented by aborted foetuses, and in these only
neuropathological findings were available. The remaining
patients were further investigated through a neuroimag-
ing, neurological and neuropsychological protocol that
was sent to all centers participating in the study. As-
sessment of younger children less than 4 years of age
was performed using appropriate developmental scalesTable 1 Mutations identified in the present study*
Exon/intron Nucleotide change Type of mutation Pr
Ex 3 c.115C > T Nonsense p.Q
c.225C > G Missense p.N
c.275_276delCT Frameshift p.S
Ex5 c.400_403delGAAA Frameshift p.E
Ex 6 c.508_509delGA Frameshift p.D
Ex 8 c.710dupA Frameshift p.Y
c.710dupA Frameshift p.Y
c.710dupA Frameshift p.Y
Ex 9 c. 914_915delAA Frameshift p.R
Ex 11 c.1059 T > A Nonsense p.Y
c.1099C > T Nonsense p.R
c.1099C > T Nonsense p.R
c.1128A > G Splicing -
Int 11 c.1130-1G > A Splicing -
Ex 12 c.1193_1196del AATC Frameshift p.Q
Genomic rearrangements:
Del ex 11 - Genomic deletion -
Del ex 7-10 - Genomic deletion -
*As reference, the A of the ATG translation initiation start site of the coding sequen
nucleotide +1.
NA, non-ascertained.
onot reported before.such as the GMDS (see methods). These studies allowed for
the identification of a wide spectrum of CNS involvement
including structural abnormalities, neurological symptoms
and signs and cognitive impairment. Additional file 1:
Table S1 summarizes the genetic information and the
clinical information (ethnicity, mail clinical features and
nurological findings) for the entire cohort of patients.
Neuroimaging
Among the dataset of patients displaying a neurological
phenotype, forty-two cases (including two aborted fetuses)
underwent MRI, two of these cases were also subjected to
post mortem examination (namely a 7 year old girl who
died of traumatic injury and one of the aborted fetuses),
and 29 underwent brain CT scans or CUS as newborns.
Eight patients among those subjected to CT scans had
normal findings. Sixty-three cases (88.73%), including 42
patients subjected to MRI and 21 subjected to CT scans,
showed one or more structural anomalies, namely: 45
cases displayed corpus callosum defects (agenesis or hypo-
plasia, ACC); arachnoid cysts were observed in 25 cases;
23 cases presented malformations of cortical development
(MCD) (neuronal migration/organisation disorders, pachy-
gyria, gray matter heterotopias, cortical dysplasia, polymi-
crogyria and schizencephaly); cerebellar developmental
anomalies (CDAs) (cerebellar hypoplasia, isolated oredicted protein Case Mutation origin Patient ID
39X Sporadic De novo 146°
75K Sporadic De novo 145°
92CfsX115 Sporadic De novo 169
134IfsX143 Sporadic De novo TH2
170FfsX173 Sporadic NA TH3
238VfsX239 Sporadic NA 148
238VfsX239 Sporadic De novo 150
238VfsX239 Sporadic NA TH4
306SfsX307 Sporadic De novo 155°
353X Sporadic De novo 159°
367X Sporadic De novo 156
367X Sporadic NA 147
Sporadic De novo 151°
Sporadic De novo TH5
398LfsX400 Sporadic De novo 161
Sporadic NA 139°
Sporadic NA 141°
ce for OFD1 (Entrez nucleotide accession number NM_003611) is referred to as
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or dysplasia) were described in 20 cases (DWM, in par-
ticular, was observed in 5 patients); cerebral atrophy
and/or hypoplasia were detected in 9 cases; hydrocephalus
or ventriculomegaly was observed in 8 cases; porence-
phaly was recognized in 3 cases, brain stem anomalies
(hypoplastic and/or dysmorphic pons and/or medulla) in
2 cases, and hypothalamic hamartoma was found in one
case. Table 2 summarizes these findings. Some patients
displayed a more complex pattern of malformations (in-
cluding agenesis of the corpus callosum, polymicrogyria,
intracranial cysts, ponto-cerebellar hypoplasia and sube-
pendymal and subcortical heterotopia), while only mild
anomalies could be detected in other cases, thus indicating
a great degree of variability in the CNS involvement
observed in these cases (Figure 1).
Neurological impairment
Sixty-nine out of the 71 patients showing CNS involvement
were examined for signs and symptoms of neurological
impairment. The two remaining cases were represented
by aborted foetuses and were thus excluded from further
evaluations. Table 3 describes the frequency of neuro-
logical disorders observed in patients with CNS structural
anomalies (61 cases) compared to patients with normal
neuroimaging findings (8 cases). Neurological impairment
in patients with CNS structural abnormalities included
motor delay (mild, moderate or severe) present in 15
cases, epilepsy - both generalized and focal seizures
(infantile spasms, absences, tonic-clonic fits, drop at-
tacks, focal motor seizures) – reported in 9 cases, hypo-
tonia present in 5 cases (truncal in two cases and both
truncal and limb in three cases), cranial nerve disorders in
5 cases (affecting, oculomotor and/or swallowing nerves),
sensorineural hearing loss in 4 cases, spasticity of bilateral
lower extremities in 3 cases, motor coordination deficits -Table 2 Central Nervous System (CNS) structural abnormalitie
CNS structural abnormalities: type MRI/p.m.*
Agenesis/hypoplasia of the Corpus Callosum (ACC) 34/42 (80.95)
Intracerebral arachnoid cysts 19/42 (45.24)
Malformations of cortical development (MCDs) 22/42 (52.38)
Cerebellar developmental anomalies (CDAs) 18/42 (42.86)
- Dandy-Walker Malformation (DWM) 5/42 (11.90)
Cerebral atrophy/hypoplasia 5/42 (11.90)
Hydrocephalus/ventriculomegaly 6/42 (14.29)
Porencephaly 1/42 (2.38)
Brain stem anomalies 2/42 (4.76)
Hypothalamic hamartoma 1/42 (2.38)
Total 42/42 (100)
*p.m. : post-mortem evaluation.
apercentages calculated on the total number of cases displaying CNS involvement.
bpercentages calculated on the entire cohort of cases.both postural static and dynamic (gait ataxia ) – in 2
patients, hemiparesis in 2 cases and nystagmus in 2 cases.
Patients without CNS structural abnormalities only
showed either mild neurologic signs, such as motor co-
ordination disorders (1 case) and/or mild motor delay
(2 cases), or cognitive deficits (intellectual disability or
selective disorders, see below). Epilepsy in one patient
of the latter group may have the characteristics of a
functional, not structural, disorder.
Neuropsychological assessment
A protocol for developmental and neuropsychological
assessments of the 69 patients showing signs of CNS
involvement (see above) was proposed to the participating
centers. Twenty-two cases were reported to have normal
cognitive levels on the basis of normal academic perfor-
mances and/or normal adaptive functioning. Two cases
were reported to have normal cognitive levels on the basis
of specific neuropsychological testing. Forty-seven cases
were referred as mentally impaired; for twenty-four of
these cases, the assessment was based only on clinical
observation, while for the other twenty-three patients,
specific neurodevelopmental and/or neuropsychological
testing was applied. In particular, four cases (ID50,
ID13, ID39 and ID6) underwent a complete protocol
assessing cognitive levels, and selective cognitive abilities
(memory, learning and language). A complete description
of three of these cases is reported below. The neuro-
psychological data collected revealed that, 40/69 cases
(58%) showed a global intellectual disability (which were
mostly mild, but moderate-severe deficits were also identi-
fied), and 7/69 cases (10%) demonstrated with selective
cognitive impairment (defined on the basis of a normal
full scale IQ) such as language disorders, learning difficul-
ties or memory problems. Our results indicate that >68%
of OFD1 cases from our selected cohort present somes in our cohort of patients
eco/CT Tot. N° (%)a Tot. N° (%)b
11/29 (37.93) 45/71 (63.38) 45/117(38.46)
6/29 (20.69) 25/71 (35.21) 25/117(21.36)
1/29 (3.45) 23/71 (32.39) 23/117(19.65)
2/29 (6.9) 20/71 (28.17) 20/117(17.09)
0/29 (0) 5/71 (7.04) 5/117(4.27)
4/29 (13.79) 9/71 (12.68) 9/117(7.69)
2/29 (6.9) 8/71 (11.27) 8/117(6.83)
2/29 (6.9) 3/71 (4.22) 3/117(2.56)
0/29 (0) 2/71 (2.82) 2/117(1.7)
0/29 (0) 1/71 (1.41) 1/117(0.85)
21/29 (72.41) 63/71 (88.73) 63/117(53.84)
Figure 1 Overview of the typical neuroimaging findings in ofd1 patients. A, b: Case ID50, 52 months (OFD1 mutation: 337 C > T; Q113X).
a) Coronal TSE T2-weighted image: corpus callosum agenesis. Two arachnoid cysts (arrows) are respectively located upper to the roof of the third
ventricle and on the right side of the falx. Note the “Texas longhorn” configuration well depicted only on the left side where the Probst bundle is also
well visible. b) Axial TSE T2-weighted image: thinning and parallel orientation of the lateral ventricles. Bilateral fronto-mesial subcortical heterotopias
(arrows) are evident along the anterior part of the interhemispheric defect. The bigger one anteriorly truncates the right Probst bundle that is thinner
than the controlateral. A subtle thickening of the frontal cortical surfaces suggestive of polymicrogyria is also evident. Note the thin multiple dilatations
of Virchow-Robin spaces at the posterior white matter. c, d: Case ID39, 8-year-old (OFD1 mutation: 290 A > G; E97K). c) Sagittal TFE T1-weighted 3D
images: note the frontal and parietal clefts surrounded by irregular and thickened grey matter consistent with infolding polymicrogyria (arrow). d) Axial
TSE T2-weighted image: the interhemispheric defect is caused by the agenesis of the corpus callosum. Two arachnoid cysts are located between the
outpouching of the third ventricle (arrow) and the enlarged left lateral ventricle. On the left side, polymicrogyria of the frontal cortical surface, as well
as the periventricular deep portion of the infolding, are both well appreciable. e, f: Case ID13, 13-year-old (OFD1 mutation: 247CAA > TAA; Q83X).
e, f) Axial TFE T1weighted 3D and TSE T2 images: note some mild dilatation of Virchow-Robin spaces at the supratentorial white matter (arrows).
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cohort our data indicate that 40.8% of patients present
some form of intellectual disability (47/115). Purely
psychiatric disorders were quite rare: Attention DeficitHyperactivity Disorder (ADHD) was found in two patients
(one with and one without CNS anomalies) and Bipolar
Disorder was observed in only one patient displaying CNS
abnormalities.
Table 3 Neurological disorders in our cohort of patients
Neurological disorders: type Patients with CNS structural
abnormalities % (n°)
Patients without CNS structural
abnormalities % (n°)
Total number of patients % (n°)
Motor delay 24.6 (15/61) 25 (2/8) 24.64 (17/69)
Epilepsy 14.75 (9/61) 12.5 (1/8) 14.49 (10/69)
Hypotonia 8.2 (5/61) 0 (0/8) 7.25 (5/69)
Cranial nerve disorders 8.2 (5/61) 0 (0/8) 7.25 (5/69)
Sensorineural hearing loss 6.56 (4/61) 0 (0/8) 5.8 (4/69)
Spasticity 4.92 (3/61) 0 (0/8) 4.35 (3/69)
Motor coordination deficits 3.28 (2/61) 12.5 (1/8) 4.35 (3/69)
Hemiparesis 3.28 (2/61) 0 (0/8) 2.9 (2/69)
Nystagmus 3.28 (2/61) 0 (0/8) 2.9 (2/69)
Total 55.74 (34/61) 37.5 (3/8) 53.62 (37/69)
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observed both in patients displaying CNS structural anom-
alies and in those with normal neuroimaging findings. Iso-
lated selective disorders were observed in 3/61 patients
(4.92%) of the first group and in 4/8 (50%) patients of the
second group. As expected moderate/severe intellectual
disability was detected only in patients with CNS struc-
tural abnormalities (7/61, 11%).Selected case reports
To illustrate the complexity and variability of the neuro-
logical phenotype observed in OFD1 we report the neuro-
imaging (MRI) and neuropsychological findings in three
selected cases in detail.Table 4 Cognitive/psychiatric defects in our cohort of patient
Cognitive impairment: type Cases with CNS structura
abnormalities % (n°)
Mild MI/borderline intelligence: 32.79 (20/61)
Moderate/severe MI 11.47 (7/61)
MI (severity not specified): 14.75 (9/61)
Total 59.02 (36/61)
Selective cognitive impairment: 4.92 (3/61)
i) language disorders 3.28 (2/61)
ii) learning difficulties 1.64 (1/61)
iii) memory problems 0 (0/61)
Total (MI + selective cognitive impairment) 63.93 (39/61)
• Clinical assessment 34.43 (21/61)
• Specific testing 29.51 (18/61)
Psychiatric disorders: type
ADHD 1.59 (1/61)
Bipolar disorders 1.59 (1/61)
Total 3.28 (2/61)
MI: intellectual disability.Case ID50, 52 months (OFD1 mutation: 337 C > T; Q113X)
History and neurological examination This young girl
was born of non-consanguineous parents after an unevent-
ful pregnancy and delivery; her birth weight was 3,150
grams. She was hospitalized soon after birth because of
multiple congenital malformations (cleft lips and palate,
scoliosis, right clubfoot, supernumerary lung lobe, trigo-
nocephaly) and respiratory distress. Subsequently, she suf-
fered from recurrent upper and lower airways infections.
Neurological examination revealed a host of signs, which
included a positive Romberg sign with broad-based stag-
gering gait, dysmetria at the finger-to-nose test on the left
side together with slight weakness of the left arm, brisk
deep tendon reflexes with polyphasic left ankle jerk and
right ankle clonus and positive right Babinski sign.s
l Cases without CNS structural
abnormalities % (n°)
Total number of cases % (n°)
37.5 (3/8) 33.33 (23/69)
0 (0/8) 10.14 (7/69)
12.5 (1/8) 14.49 (10/69)
50 (4/8) 57.97 (40/69)
50 (4/8) 10.14 (7/69)
0 (0/8) 2.9 (2/69)
37.5 (3/8) 5.8 (4/69)
12.5 (1/8) 1.45 (1/69)
100 (8/8) 68.12 (47/69)
37.5 (3/8) 34.78 (24/69)
62.5 (5/8) 33.33 (23/69)
12.5 (1/8) 2.9 (2/69)
0 (0/8) 1.45 (1/69)
12.5 (1/8) 4.35 (3/69)
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http://www.ojrd.com/content/9/1/74Neuroimaging This case showed agenesis of the corpus
callosum with two interemispheric arachnoid cysts (arrows
in Figure 1a), bilaterally evident frontal polymicrogyria and
fronto-mesial subcortical heterotopias (Figure 1b) and
hypogenetic and dysplastic cerebellum (Figure 2a, b). The
pons was clearly hypoplastic (Figure 2a), while the medulla
was dysplastic due to abnormal hypertrophy on the left
side (arrow in Figure 2b) with a protuberance on its dorsal
surface (arrow in Figure 2a).Figure 2 Details of the neuroimaging findings from selected patients
Sagittal TSE T2-weighted image: a) vermis and pons hypoplasia (arrow) wit
and aqueductal stenosis are shown together with an enlargement of the fo
on the dorsal surface of the medulla is also evident (arrow). b) Axial IR T1-W
than the controlateral one (arrow). Also note the hypoplasia of the cerebel
side. c, d, e: Case ID39, 8-year-old (OFD1 mutation: 290 A > G; E97K). c) Sagit
rotation (arrow) and dysmorphism of the vermis and flat ventral pons (arro
Axial TFE T1-weighted 3D image: little protuberance on the right side of the p
(square) characterized by thickening and horizontalization of the superior cere
is present in the middle of the midbrain. The anomalous orientation of th
f, g: Case ID13, 13-year-old (OFD1 mutation: 247CAA > TAA; Q83X). f) Sagitt
cerebellar fissure and hypoplasia of the declive lobule (arrow). g) Axial TSE
abnormal orientation of the folia (arrows).Neuropsychological assessment Developmental assess-
ment (Additional file 2: Table S2) by means of the GMDS
showed a global developmental delay (mental age of
31.5 months) with worse performances in the locomotor
domain. Language assessment revealed severe articulatory
problems that made speech nearly incomprehensible,
except for a few common words; language comprehension
and grammar were quite appropriate for the developmen-
tal level. Behavioural assessment by means of the CBCL. a, b: Case ID50, 52 months (OFD1 mutation: 337 C > T; Q113X). a)
h anomalous elongation of the medulla, slight swelling of the tectum
urth ventricle and of the posterior fossa. An anomalous protuberance
image: dysmorphism of the left side of the medulla that is bigger
lar hemispheres with anomalous orientation of the folia on the right
tal TFE T1weighted 3D image: marked hypogenesis, anticlockwise
w). The fourth ventricle and the posterior fossa are both enlarged. d)
ons (arrow). e) Axial TFE T1 weighted image: typical “molar tooth sign”
bellar peduncles. A mild hypointense dilatation of a Virchow-Robin space
e cerebellar folia is also visible in the superior part of the cerebellum.
al TFE T1-weighted 3D image: abnormal dilatation of the primary
T2-weighted image: enlargement of the right biventer lobule with
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http://www.ojrd.com/content/9/1/74detected problems in the attention domain (Additional
file 3: Table S3).
Case ID39, 8-year-old (OFD1 mutation: 290 A > G; E97K)
History and neurological examination This girl was
born following a caesarean section at the 29th week of
gestation after an abnormal pregnancy with oligohydram-
nios and inadequate intrauterine growth. Her birth weight
was 990 grams. She was transferred to the neonatal inten-
sive care unit due to respiratory distress and intracranial
haemorrhage. Multiple congenital anomalies were also
noted: cleft tongue, oral aberrant frenula, syndactyly, facial
dysmorphisms (hypotelorism and anteverted nostrils),
interatrial defect (ostium secundum), corpus callosum
agenesis, right kidney hypoplasia, and presence of bilateral
renal cysts. Subsequently, she suffered from febrile sei-
zures and also from afebrile fits that were not considered
to be of epileptic origin. Upon neurological examination,
the girl showed a clumsy gait with difficulty walking on
tiptoes. Moreover, clumsiness was also evident in her
spontaneous motor activities. Muscle tone was normal as
well as deep tendon reflexes.
Neuroimaging The corpus callosum was absent with
two interhemispheric arachnoid cysts (Figure 1d). Frontal
and parietal polymicrogyria were evident (arrows in
Figure 1c,d).
The cerebellum was hypogenetic and dysplastic, show-
ing an upper anticlockwise rotation of the vermis (arrow
in Figure 2c). A typical “molar tooth” sign was evident
(square in Figure 2e). The posterior fossa and the fourth
ventricle were both enlarged (Figure 2c), and the ventral
pons was flat with a protuberance on its right side (arrows
in Figures 2c,2d).
Neuropsychological assessment Developmental assess-
ment (Additional file 2: Table S2) evaluated with the GMDS
showed a global developmental delay in the moderate-
severe range (mental age of 35 months). The best per-
formance was in the “practical reasoning” domain, while
the locomotor subscale gave the lowest score. Behavioural
assessment by means of the CBCL revealed clear-cut atten-
tion problems (Additional file 3: Table S3). On the whole,
the cognitive profile was similar to the one described for
the previous patient.
Case ID13, 13-year-old (OFD1 mutation: 247CAA > TAA;
Q83X)
History and neurological examination This girl was
born at term weighing 3,450 grams after a pregnancy
complicated by hyperemesis and recurrent abdominal
pain. A diagnosis of OFD1 syndrome was entertained in
the neonatal period due to the presence of cleft tongue,
supernumerary gingival frenula, nasal and forehead milia,and nuchal alopecia. Polycystic kidney disease, as well as a
mitral valve prolapse, was subsequently detected with no
remarkable clinical consequences. Neurological exam-
ination was normal.
Neuroimaging The brain structure was normal except
for a mild dilatation of some Virchow-Robin spaces
(arrows in Figure 1e,f ). The cerebellum showed an ab-
normal dilatation of the primary cerebellar fissure with
hypoplasia of the declive lobule (arrow in Figure 2f )
and an enlargement of the right hemispheric biventer
lobule (arrows in Figure 2g).
Neuropsychological assessment Global intellectual
functioning at the WISC-III scale was at the lowest nor-
mal score; more precisely, the Verbal Comprehension
Index was very low, while the Perceptual Organization
Index as well as Freedom from Distractibility Index and
Processing Speed Index, was in the normal range. Execu-
tive functions assessed by the “Wisconsin Card Sorting
Test” were impaired by a high number of perseverant an-
swers. Verbal fluency was poor with associated semantic-
lexical difficulties and problems in recalling words or
names (lexical deficit of the anomia type). Long-term ver-
bal memory was borderline while both overall non-verbal
memory and short-term verbal memory were within the
normal range. Details of the aforementioned neuropsycho-
logical assessment are given in Additional file 4: Table S4).
Behavioral assessment by means of the CBCL revealed a
withdrawn profile pointing to reduced social intercourse
and introversion (Additional file 3: Table S3).
Genotype/phenotype correlation Statistical analysis was
performed but no significant correlations could be iden-
tified between the site and extent of CNS abnormalities,
the cognitive impairment and the type and position of
mutations.
Discussion
We report a detailed characterization of the CNS in-
volvement observed in a large cohort of OFD type 1
cases. In our study the CNS involvement is defined as
the presence of neurological symptoms, and/or cognitive/
behavioral abnormalities and/or brain structural abnormal-
ities. Our study, based uniquely on patients with clearly de-
fined pathogenic mutations, indicates that over 60% of the
full cohort of 117 cases displays a CNS involvement. These
results are in agreement with similar findings in the litera-
ture [7,9,41]. We also compared results from this study to
those described in Bisschoff et al. (Table 5). Our results
indicate that, in our full cohort, 63 out of 117 cases (53.8%)
display brain malformations/structural abnormalities. This
percentage rises up to 88.7% in our selected cohort of
71 cases subjected to neuroimaging studies and could
Table 5 CNS involvement in OFD type I
CNS involvement in OFD1 Bisshoff et al. [9] This report Tot. N° (%)
Total CNS involvement 20/31 (64.5) 71/117 (60.68) 91/148 (61.49)
Available MRI 7/31 (22.5) 42/71 (59.15) 49/102 (41.18)
Total CNS malformations NR 63/71 (88.73)* 63/71 (88.73)
Agenesis/dysgenesis Corpus Callosum 13/16 (81.2) 34/42 (80.95)a 47/58 (81.03)
Malformations cortical development (MCDs) 4/6 (66.6) 22/42 (52.38)a 26/48 (54.17)
Cysts 7/13 (53.8) 19/42 (45.24)a 26/55 (47.27)
Hydrocephalus/Porencephaly 8/13 (61.5) 7/42 (16.66)a 15/55 (27.27)
Cerebellar developmental anomalies (CDAs) NR 18/42 (42.86)a 18/42 (42.86)
Cerebral atrophy/hypoplasia NR 5/42 (11.90)a 5/42 (11.90)
Brain stem anomalies NR 2/42 (4.76)a 2/42 (4.76)
Hypothalamic hamartoma NR 1/42 (2.38)a 1/42 (2.38)
MI/ psychomotor retardation 12/26 (46.1) 47/69 (68.12) 59/95 (62.1)
Epilepsy 4/25 (16.0) 10/69 (14.49) 14/94 (14.89)
NR: not reported.
MI: intellectual disability.
*based on MRI/p.m and eco/CT evaluations.
abased only on MRI/p.m findings.
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would be carried out also in asymptomatic/mildly-affected
patients. Our results also indicate that some form of intel-
lectual disability ranging from mild to severe and selective
cognitive impairment can be detected in >68% of cases in
our selected cohort.
Statistical analysis failed to show a straightforward
genotype–phenotype correlation; however, the number of
patients analyzed and the possible importance of environ-
mental factors warrant further investigation.
Our study allowed us to determine the incidence of
the different types of CNS structural abnormalities. In
particular ACC, MCDs, CDAs, and intracerebral cysts
were the most frequently observed malformations. How-
ever, it is important to underscore that given the quite
limited definition of CT compared to MRI, particularly
for the structures of the posterior fossa, a percentage of
missed structural brain anomalies (related to the cases
who did not undergo MRI studies) should be taken into
account.
Taken together, all the above mentioned malformations
might be related to disorders of cellular migration and
proliferation in the developing brain.
We questioned whether the presence of structural brain
anomalies could be significantly associated with cognitive
and/or neurological impairment. Only intellectual disability
as a whole (mild, moderate or severe) appeared to be more
frequently associated with brain structural anomalies, while
selective neuropsychological defects (language disorders,
learning disorders, memory deficits) behaved independ-
ently. As expected, a higher prevalence of neurologic signs
was found in patients with brain malformations. MCDsand CDAs could represent a possible neurobiological basis
for the cognitive impairment observed in OFD type 1 syn-
drome. This observation is based on data demonstrating
that neuronal migration defects result in neurological im-
pairment, including in intractable epilepsy and intellectual
disability [42], and also on the accumulated evidence on
the role of the cerebellum in the context of child develop-
ment and learning processes [43].
Mutations in the OFD1 gene have also been reported
in an X-linked recessive intellectual disability syndrome
comprising macrocephaly and ciliary dysfunction [12],
Joubert (JBTS10) syndrome [13-16] and in X-linked ret-
initis pigmentosa [17].
Joubert syndrome and related disorders (JSRD) spectrum
is primarily defined by the presence of a specific neuroim-
aging hallmark- the “molar tooth sign” (MTS)-resulting
from a specific midbrain-hindbrain malformation (thick-
ened, elongated and horizontally located superior cerebellar
peduncles together with an abnormally deep interpeduncu-
lar fossa and vermian hypo-dysplasia) [44]. Additional infra-
tentorial and supratentorial neuroimaging findings reported
in JSRDs include, for the first set enlargement of the pos-
terior fossa and fourth ventricle, reduced or enlarged size
of the cerebellar hemispheres and abnormal brain stem
morphology. Supratentorial findings include migration
disorders, callosal dysgenesis, ventriculomegaly and hip-
pocampal malrotation. Encephaloceles, most often located
in the occipital regions, have also been described. The
cognitive phenotype is characterized by delayed language
and motor skills. Mild to severe intellectual disability is
often described, but exceptional cases may have borderline
or even normal intelligence [45].
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criterion for OFDVI [46]. Interestingly, two OFDVI
patients were reported to have a homozygous mutation in
TMEM216, a gene implicated in JSRD and Meckel-Gruber
syndrome (MKS) [47], and a mutation in the OFD1
transcript has been reported in an OFDVI case [48].
More recently a high frequency of mutations in C5ORF42
has been reported in OFDVI patients [49]. One out of the
71 OFD1 cases that we have analyzed displayed a typical
MTS. The neurological features observed in OFD type 1
and JSRDs suggest that OFD1 can be considered an exten-
sion of the JSRD spectrum. OFD1, OFDVI and JSRDs
could represent different levels of expression of the ciliary
dysfunction in the brain.
The spectrum of CNS malformations in MKS ranges
from total craniorachischisis to a partial agenesis of the
corpus callosum. Neuropathological studies have shown
prosencephalic dysgenesis, defects in midline formation,
polymicrogyria, heterotopias, and neuroepithelial rosettes
[50]. Neurodevelopmental defects in the form of more
subtle brain tissue- and region-specific abnormalities are
frequently reported in Bardet-Biedl (BBS) patients [51]. As
for the cognitive phenotype, a characteristic profile includ-
ing low IQ, impaired fine motor skills, and decreased
olfaction has been identified in BBS patients [52].
Our findings well correlate with the brain developmental
anomalies described in ciliopathies. In addition, we describe
the presence of characteristic features that have not been
previously reported in OFD1 proven cases. We docu-
mented cerebellar developmental anomalies including
rotation of the vermis, as well as segmental anomalies
such as hypoplasia of the declive lobule or enlargement
of the right biventer lobule and abnormal orientation of
hemispheric folia and sulci. More interestingly, for the
first time we report a peculiar dysplastic feature of the
brainstem, characterized by the presence of abnormal
protuberances. Jurich-Sekhar et al. recently described
excess tissue in the brainstem of two JSRDs cases bearing
mutations in OFD1 [15]. However, the two patients did
not display the obligatory hallmark of JSRDs, the MTS.
This dysplastic abnormality may also reflect disturbances
of patterning and cell migration related to neurodevelop-
mental functions of primary cilia.
Consistent with various neurological symptoms detected
in ciliopathic patients, most cells in the brain (including
neural progenitors and mature neurons, glial cells/astro-
cytes and ependymal cells) have primary cilia [53]. These
organelles have a definite role in brain development: brain
patterning is controlled by morphogens such as Shh, Wnt
and Fgf, which require primary cilia to effectively transduce
their signals [2,54]. Defective ciliary function resulting
in impaired signal transduction might explain the
severe malformations occurring in the early stages of
brain development. In addition, ciliary proteins havebeen implicated in control of centrosome/centriole posi-
tioning possibly leading to abnormal neuronal migration
early in development [55]. Interestingly cilia have also
been shown to orchestrate the coordinated migration and
placement of postmitotic interneurons in the developing
cerebral cortex [56,57], Moreover OFD1 has been shown
to play a role in the neuronal differentiation of embryonic
stem cells [58].
Cognitive impairment in OFD1 syndrome also questions
the role of primary cilia in more advanced brain function.
Cilia are critical regulators of Shh signaling on postnatal
precursor cells and participate in orchestrating postnatal
forebrain development and stem/precursor cell mainten-
ance [59]. Impaired Shh signaling due to cilia dysfuction
leads to defective hippocampal morphogenesis and dysreg-
ulation of mitotic activity in the mice’s postnatal brain
[59], stressing the hippocampus as a target organ for
CNS-related ciliopathic manifestations.
Interestingly, as far as neuropsychological aspects are
concerned, some common traits can be isolated, namely
a reduced ability in processing verbal information, a slow
thought process, difficulties in attention and concentration,
and notably, long-term memory deficits. Similar neuro-
psychological features associated with high percentage of
hippocampal dysgenesis were reported in a cohort of
patients with BBS syndrome [60]. Moreover, in Joubert
syndrome, Poretti et al. [61] reports on difficulties in
some executive functions as we found in our patient ID13.
In the subset of patients for whom a detailed neuro-
psychological assessment was available no significant
hippocampal abnormalities have been detected. Recent
data obtained in mouse models show that hippocampal
neurogenesis, in particular in the adult mouse, requires
intact primary cilia. It has been reported that the neur-
onal primary cilia of the hippocampal dentate gyrus are
the drivers of neurogenesis and memory formation [62].
It would be beneficial to evaluate how deficient ciliary
function affects learning and memory in patients, as
adult hippocampal neurogenesis has a crucial role in
memory, and newborn neurons of the dentate gyrus
might be involved in pattern integration and pattern
separation [63]. Evidence for involvement of cilia in
higher brain functions is now available. Loss-of-function
of the somatostatin receptor 3 (SSTR3), localized to cilia
in the neocortex and hippocampus leads to impaired ob-
ject recognition in mice, whereas the loss of other SSTRs,
not found on cilia, does not [64]. This only happens in
mature neurons inasmuch as SSTR3 is only evident in the
brain post-natally [65].
Conclusions
In conclusion our data support the finding that over
60% of OFD1 patients show neurodevelopmental de-
fects including brain structural anomalies, cognitive
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intellectual disability and selective cognitive defects),
and associated neurological disorders and signs. Our
data also revealed that cognitive impairment is ob-
served in over 40% of cases and this percentage in-
creases up to 88% in our selected cohort. On the basis
of our results a full neurological, neuroimaging and
neuropsychological evaluation is recommended to allow
a better management of OFD type 1 patients. Our
results expand our knowledge of CNS involvement in
ciliopathies. Conditional inactivation of the Ofd1 tran-
script in the murine hippocampus at different develop-
mental stages and in adult brains will help in clarifying
the role of Ofd1 and primary cilia in higher brain
functions.
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